FRANKLIN LAKES, N.J.,
Sept. 8, 2017 /PRNewswire/ -- BD
(Becton, Dickinson and Company) (NYSE:BDX), a leading global
medical technology company, announced today that it will present at
the Morgan Stanley Global Healthcare Conference 2017 on
Tuesday, September 12, 2017, at
9:10 a.m. EDT.
A live webcast of BD's presentation can be accessed from the BD
corporate website at www.bd.com/investors and will be available for
replay through Tuesday, September 19,
2017.
About BD
BD is a global medical technology company
that is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. BD leads in
patient and health care worker safety and the technologies that
enable medical research and clinical laboratories. The company
provides innovative solutions that help advance medical research
and genomics, enhance the diagnosis of infectious disease and
cancer, improve medication management, promote infection
prevention, equip surgical and interventional procedures, and
support the management of diabetes. The company partners with
organizations around the world to address some of the most
challenging global health issues. BD has nearly 50,000 associates
across 50 countries who work in close collaboration with customers
and partners to help enhance outcomes, lower health care delivery
costs, increase efficiencies, improve health care safety and expand
access to health. For more information on BD, please visit
bd.com.
Contact:
Kristen Cardillo, Communications –
201-847-5657
Monique N. Dolecki, Investor
Relations – 201-847-5378
View original
content:http://www.prnewswire.com/news-releases/bd-to-present-at-the-morgan-stanley-global-healthcare-conference-2017-300516545.html
SOURCE BD (Becton, Dickinson and Company)